FDA approved akynzeo for chemotherapy vomiting
-
Last Update: 2014-10-13
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: Medical Geography from October 10, 2014 to October 10, 2014, the U.S FDA announced on Friday that it had approved akynzeo, a drug of Japanese pharmaceutical company Weicai, to treat nausea and vomiting of cancer patients after chemotherapy This product is a compound preparation of two drugs: palonosetron, the first drug approved in 2008 to prevent vomiting within 24 hours after chemotherapy; netuptant, a drug used to treat the initial nausea and nausea within 120 hours after chemotherapy Adverse reactions in the akynzeo clinical trial included headache, fatigue, dyspepsia and constipation.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
